Tagworks’ CEO Marc Robillard is one of the speakers at Antibody Engineering & Therapeutics Europe 2018 in Amsterdam from 5-7 June.
Marc will present the company’s latest results on “Click chemistry-triggered drug release from a tumor-bound ADC” on Thursday 7 June. His lecture is part of a session on “Novel antibody-based therapeutics for cancer and immuno-oncology”
More information on the event: https://lifesciences.knect365.com/antibody-engineering-europe/speakers
Tagworks CEO Marc Robillard talks about entrepreneurship in the life sciences field and shares his experiences as co-founder of Tagworks Pharmaceuticals during the InnoBoot Session: Business meets Science at the StartupDelta Summit on Thursday April 19, 2018, in Arnhem, the Netherlands.
More information on the event: https://startupdeltasummit.com/overdesummit/
Tagworks CSO Raffaella Rossin presents the company’s latest research achievements on ‘In vivo click chemistry’ at the 19th European Symposium on Radiopharmacy and Radiopharmaceuticals (ESRR) in Groningen, the Netherlands on Friday, April 6, 2018.
More information: http://www.esrr.info/welcome-address/